Cerebras Q3 10-Q: Revenue Up 55% to $210.8M but GAAP Loss Widens to $161.2M
CBRS sits 46% above its 52-week low of $77.841.
Summary
Cerebras' Q3 10-Q confirms 55% revenue growth to $210.8M but reveals a $161.2M GAAP loss, gross margin collapsing to 20%, and an OpenAI capacity delivery shortfall that has already triggered service credits.
Key Events · Earnings and Guidance · CBRS
-
Q3 Revenue Grows 55% to $210.8M
Total revenue rose to $210.8M from $135.7M a year ago, with cloud and other services up 265% to $141.9M while hardware fell 29% to $68.9M.
-
GAAP Loss Widens on Stock Comp
Net loss was $161.2M (-$0.67 per share) versus $22.2M a year ago; stock-based compensation totaled $155.1M in the quarter and $541.7M for nine months.
-
Gross Margin Collapses to 20%
Total gross margin fell to 20% from 41% as cloud and other services cost of revenue jumped 229% to $107.4M and customer warrant amortization reduced revenue by $36.4M.
-
OpenAI Capacity Delivery Shortfall
Cerebras delivered less capacity to OpenAI than the MRA contemplated; service credits began accruing October 1, 2026, and delays may continue through part of 2027, with tranches terminable if uncured 90 days past milestones.
Analysis · CBRS · Manufacturing
The headline revenue beat was already out via the same-day 8-K, but the full 10-Q shows what the press release glossed over: gross margin collapsed to 20% from 41% a year ago as cloud costs (up 229%) and $155.1M of stock-based compensation swamped the top line, producing a $161.2M GAAP loss versus $22.2M a year ago. More importantly, the filing discloses that Cerebras has delivered less capacity to OpenAI than the MRA requires, service credits began accruing October 1, 2026, and delays may run through part of 2027 — a direct threat to the $26.1 billion remaining performance obligation that underpins the growth story. Add continuing material weaknesses in internal controls and roughly $8.5 billion of not-yet-commenced data center lease obligations, and the risk profile is meaningfully worse than the revenue headline suggests.
How filings like this one have moved
In the 30 days to Nov 12, 2026, 47.3% of the 1873 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.17%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CBRS was trading at $113.95 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $21.9B. The 52-week trading range was $77.84 to $386.34. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.